Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Greg Zante

CFO at Viking Therapeutics, Inc. (VKTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.8M

Reported trades

Filed Stock Type Shares Price Value Since
Jul 29SEC VKTXViking Therapeutics, Inc. Sell 21,217212,204 held (−9%) $33.47 $710K -14.8%
Jan 5SEC VKTXViking Therapeutics, Inc. Sell 31,961215,571 held (−13%) $32.30 $1.0M -11.7%
Jan 5SEC VKTXViking Therapeutics, Inc. Sell 13,900201,671 held (−6%) $33.38 $464K -14.6%
Jan 5SEC VKTXViking Therapeutics, Inc. Sell 10,300191,371 held (−5%) $34.24 $353K -16.7%
Jan 5SEC VKTXViking Therapeutics, Inc. Sell 1,500189,891 held (−1%) $32.09 $48K -11.2%
Oct 28SEC VKTXViking Therapeutics, Inc. Sell 6,185173,592 held (−3%) $35.00 $216K -18.5%